Rox Medical Inc.
5825 Avenida Encinas
Carlsbad
California
92008-4401
United States
Tel: 760-431-2406
17 articles about Rox Medical Inc.
-
ROX Medical, Inc. Hires Dr. Sackner-Bernstein as CMO and Executive VP of Clinical and Regulatory Affairs
12/18/2018
ROX Medical Inc. today announced the appointment of Jonathan Sackner-Bernstein, MD as its Chief Medical Officer and Executive Vice President of Clinical and Regulatory Affairs.
-
ROX Medical Announces Sustained Improvements in Patients With Uncontrolled Hypertension Treated With the ROX Coupler
10/27/2017
ROX Medical announced the publication of 12-month outcomes of the ROX CONTROL HTN study in the prestigious journal, Hypertension.
-
Rox Medical CONTROL HTN-2 Clinical Trial; First Procedure Performed
10/5/2017
-
SoCal's Rox Medical Rakes in $40 Million Financing
9/6/2016
-
Rox Medical Inc.'s Paper Clip-Sized Implant Reduces High Blood Pressure
1/29/2015
-
Rox Medical Inc. Presents Positive Data For CONTROL-HTN Resistant Hypertension Trial
9/17/2014
-
Rox Medical Inc. Completes Enrollment In CONTROL-HTN Trial
4/14/2014
-
First German Patient Enrolled Pushes Rox Medical Inc. Past Halfway Point in CONTROL-HTN trial
8/20/2013
-
Barts Hospital, London Enrolls First Patients in Rox Medical Inc.'s CONTROL-HTN Resistant Hypertension Trial
3/25/2013
-
Rox Medical Inc. Enrolls First UK Patients in CONTROL-HTN Hypertension Trial at Eastbourne General Hospital
3/18/2013
-
Rox Medical Inc. Enrolls First Patients in Ireland for CONTROL-HTN Hypertension Trial at Beaumont and Mater Private Hospitals
3/5/2013
-
Rox Medical Inc. Enrolls First Patient in Randomized Controlled Hypertension Trial of AV-Coupler
10/19/2012
-
Rox Medical Inc. Raises $6 Million
9/7/2012
-
California Medical Device Startup, Rox Medical Inc. Ttreating COPD Raises $5 Million in Search of $9 Milllion
8/20/2012
-
Rox Medical Inc. Announces First Clinical Use of the ROX FLO2W Procedure for the Treatment of High Blood Pressure in Resistant Hypertension Patients
10/31/2011
-
Rox Medical Inc. Initiates First Commercial Activities in Germany of Minimally Invasive CO2UPLER Implant in Conjunction with a Phase IV Registry for Patients with Chronic Obstructive Pulmonary Disease (COPD)
12/2/2010
-
Rox Medical Inc. Raises $35 Million
6/2/2008